Granting Stock Acquisition Rights to Directors and Employees
First written in FY2023-Q2. 3 of 5 entries say "Advanced", first in FY2024-Q2. Latest entry: FY2025.
- FY2025AdvancedAnnual report
「Exercised 2,700 800 — — — Unexercised balance 46,100 19,300 39,900 49,900 59,300」
The company exercised 2,700 shares under the Fifth Series of Stock Acquisition Rights and 800 shares under the Sixth Series, and updated the unexercised balance for each series. The Ninth Series has 59,300 unexercised shares remaining. - FY2025-H1Update to grant detailsAnnual report
「Resolution date 6 September 2024 Categories and number of grantees (people) Directors of the company 5 Employees of the company 18 Number of stock acquisition rights (rights) * 600 (Note 1) Class, description and number of shares underlying the stock acquisition rights (shares) * Common shares 60,000 Exercise price per share (yen) * 4,050 (Note 2)」
For the Ninth Series of Stock Acquisition Rights approved on 6 September 2024, the company states that the grantees were 5 directors and 18 employees, with 600 rights covering 60,000 shares and an exercise price of ¥4,050. - FY2024AdvancedAnnual report
「Ninth Series of Stock Acquisition Rights Resolution date 6 September 2024 Categories and number of grantees (people) Directors of the company 5 Employees of the company 11 Number of stock acquisition rights (rights) * [593] Class, description and number of shares underlying the stock acquisition rights (shares) * Common shares [59,300] Exercise price per share (yen) * 4,050 (Notes 2 and 5) Exercise period From 25 September 2024 to 24 September 2034」
The company disclosed that, during the period through the filing date, it granted the Ninth Series of Stock Acquisition Rights to 5 directors and 11 employees. The number of underlying shares was 59,300, and the exercise price was ¥4,050 per share. - FY2024-Q2AdvancedAnnual report
「Resolution date 26 December 2023 Categories and number of grantees (people) Directors of the company 5 Employees of the company 19 Number of stock acquisition rights (rights) * 499 (Note 1) Class, description and number of shares underlying the stock acquisition rights (shares) * Common shares 49,900 (Note 1) Exercise price per share (yen) * 3,740 Exercise period From 18 January 2024 to 17 January 2034」
On 26 December 2023, the company granted 499 stock acquisition rights covering 49,900 shares to 5 directors and 19 employees. The exercise price was ¥3,740 per share, and the exercise period is from 18 January 2024 to 17 January 2034. - FY2023-Q2First statedAnnual report
「Resolution date 21 December 2022 Categories and number of grantees (people) Directors of the company 5 Employees of the company 14 Number of stock acquisition rights (rights) * 619 (Note 1) Class, description and number of shares underlying the stock acquisition rights (shares) * Common shares 61,900 (Note 1) Exercise price per share (yen) * 1,650 (Note 2) Exercise period From 19 January 2024 to 18 January 2033」
On 21 December 2022, the company granted 619 stock acquisition rights covering 61,900 shares to 5 directors and 14 employees. The exercise price was ¥1,650, and the exercise period is from 19 January 2024 to 18 January 2033.